The National Institute on Drug Abuse (NIDA) is offering cooperative agreement grants for the Medication Initiative for Tobacco Dependence (MITD). This grant is for establishing a new public-private Product Development Partnership (PDP) to discover and develop safe, effective medications for treating tobacco dependence, including aids for smoking cessation. The initiative comprises a one-year planning phase (UH2) to explore drug discovery opportunities, leading to an implementation and execution phase (UH3). In the UH3 phase, a selected cooperative agreement recipient will serve as the PDP’s Managing Partner, conducting extensive research and development. The overarching purpose is to fulfill regulatory requirements for marketing approval in the US, addressing a significant public health challenge.
Opportunity ID: 72993
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-11-015 |
| Funding Opportunity Title: | Medication Initiative for Tobacco Dependence (MITD): A New Product Development Partnership (PDP)(UH2/UH3) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 22, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Apr 26, 2011 |
| Current Closing Date for Applications: | Apr 26, 2011 |
| Archive Date: | May 27, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education City or township governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Independent school districts Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Small businesses State governments Special district governments Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign (non-U.S.) components of U.S. Organizations are allowed |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The National Institute on Drug Abuse (NIDA) invites cooperative agreement applications from qualified non-profit, private and academic researchers/organizations to participate in the planning and execution of a new public-private partnership (PPP). The purpose of a one-year planning phase (UH2) is to provide support for the systematic study directed toward fuller scientific understanding of the opportunities in the area of drug discovery and development for tobacco dependence, with the ultimate goal of establishing a PPP, specifically, a Product Development Partnership (PDP). The mission of the PDP is to develop safe and effective medications for the treatment of tobacco dependence, including aids for smoking cessation. Phase two (UH3) funding will be utilized to support the implementation and execution phase of the PDP, with one selected cooperative agreement recipient assuming the role of the PDPs Managing Partner. In this subsequent phase, the PDP will conduct a wide array of research and development (R&D) projects aimed at the fulfillment of regulatory requirements for approval for marketing in the US. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-11-015.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.279 | ADOBE-FORMS-B1 | ADOBE-FORMS-B1 | PKG00035090 | Mar 26, 2011 | Apr 26, 2011 | View |
Package 1
Mandatory forms
72993 RR_SF424_1_2-1.2.pdf
72993 RR_OtherProjectInfo_1_3-1.3.pdf
72993 RR_KeyPersonExpanded_1_2-1.2.pdf
72993 RR_Budget-1.1.pdf
72993 PerformanceSite_1_4-1.4.pdf
72993 PHS398_ResearchPlan_1_3-1.3.pdf
72993 PHS398_CoverPageSupplement_1_4-1.4.pdf
72993 PHS398_Checklist_1_3-1.3.pdf
Optional forms
72993 RR_SubawardBudget-1.2.pdf
72993 PHS_CoverLetter_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
